Turning a Dormant Patient Registry Into a Real Recruitment Channel
A registry only pays off if its fields match the questions protocols ask and the contact data still works. How to structure, grow, and maintain one that produces enrollments.
By Trialflow Team
Most sites have a registry. Fewer have a registry that produces enrollments. The difference usually isn't the size of the list — it's whether the data in it maps to the questions protocols actually ask, and whether anyone has talked to those people in the last year.
A registry is a dataset, not a mailing list
If your registry has names, emails, and a free-text "interested in" field, you have a mailing list. When a diabetic nephropathy study lands with an eGFR window and a metformin exclusion, you can't query a mailing list. You end up blasting everyone, annoying your database, and converting almost nobody.
Structure the registry around the variables that gate eligibility across your therapeutic areas. At minimum, capture:
- Date of birth, not age — age drifts and recalculating from a stored number is a maintenance problem
- Primary conditions as coded entries from a controlled list, not free text
- Key medications by class, especially the ones that routinely exclude (biologics, insulin, anticoagulants, immunosuppressants)
- Recent relevant labs where patients reasonably know them (A1c, eGFR, BMI inputs)
- Study participation history, including washout-relevant end dates
- Contact preference and best time window
- Consent to be contacted, with the date and the exact language they agreed to
That last item matters more than people assume. Registries built before a site had explicit re-contact language often can't be used for anything, and nobody discovers this until a sponsor asks how the list was assembled.
Build it from the exits, not just the entrances
Sites commonly pour effort into new registry signups while ignoring the richest source they already have: people who cycled through screening. Pre-screen failures, consented screen failures, and participants who completed a study are all better registry candidates than a cold web lead. They've been to your office. They know the parking situation. They've met your coordinators.
Make registry entry a standard step at three points:
- Pre-screen disqualification — ask on the call, while you have them
- Screen failure visit close-out — build it into the visit checklist
- End of study — the exit conversation, when goodwill is highest
If these three handoffs are reliable, your registry grows as a byproduct of normal operations rather than as a separate campaign.
Decay is the real enemy
Contact data goes stale fast. Phone numbers change, people move, health status shifts. A registry that hasn't been touched in two years will typically yield reach rates low enough that coordinators stop trusting it — and once they stop trusting it, they stop using it, and it dies.
Run a light touch every six to nine months. Not a recruitment pitch — a short, useful note: a study-results summary, a health-awareness item for their condition, a one-click "is this still your number?" link. Track bounces and update or retire records. Flag anything untouched for 24 months as cold and exclude it from reach-rate math so your metrics stay honest.
Measure it like a channel
Treat the registry as a recruitment source with its own numbers: records queried, contacted, pre-screen pass rate, consented, enrolled. Compare that to paid media and referrals on a cost-per-enrolled basis. In most site datasets the registry wins decisively on cost — which is the argument you need when you ask for coordinator hours to maintain it.
The practical test: when a new protocol arrives, can someone pull a credible candidate list in under an hour? If not, the fix is structure and hygiene, not more signups.
Enrolling studies shouldn't be this hard
Trialflow gives research sites one platform for lead management, AI trial matching, and recruitment analytics.
Request a Demo